Text Size

Site Search powered by Ajax




Alfthan, A. Selenium and Risk to Myocardial Infarction. Lancet, February 22, 1984.

Altura, R.M. & B.T. Altura. Magnesium and Contraction of Smooth Muscle Relationship to Vascular Disease. Fed Proc, 40. 1981.

Barker DJ: Fetal nutrition and cardiovascular disease in later life. Br Med Bull, 1997 Jan, 53:1, 96-108.

Bartels, GL et al., Effect of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris. Am. J. Cardiology, 1994, 74(12): 5 -30.

Conte A et al., Protection of adenylate pool and energy charge by L-carnitine and coenzyme Q during energy depletion in rat heart slices. Int J Tissue React, 1990, 12:3, 187-91.

Dyerberg, J. & H.O. Bang. Eicosapentaenoic Acid and Prevention of Atherosclerosis. Lancet. July 15, 1978.

Feuerstein G et al., Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors. J Lipid Mediat Cell Signal, 1997 Mar, 15:3, 255-84.

Fruhwald FM et al., Subclinical thyroid disorders in patients with dilated cardiomyopathy. Cardiology, 1997 Mar-Apr, 88:2, 156-9.

Ginter, E. Pretreatment of Serum Cholesterol and Response to Vitamin C. Lancet. November 3, 1979.

Grynberg A & Demaison, L: Fatty acid oxidation in the heart. J Cardiovasc Pharmacol, 1996, 28 Suppl 1:, S11-7.

Gupta HL et al., Coxsackie B virus in the etiology of heart diseases in Delhi. J Commun Dis, 27:223-8, 1995 Dec.

Hamilton, H.K. ed. 1982. Professional Guide To Diseases Intermed Communications Inc. Pub, Springfield, Massachusetts. 1323 pp.

Hui, Y.H. 1983. Human nutrition and diet therapy. Wadsworth, Inc; Belmont, California. 1039 pp.

Hwang, D.H. & J. Donovan. In Vivo Effects of Vitamin E on Arachidonic Acid Metabolism in Platelets. J Of Nutri, 112. 1982.

Isselbacher, K.J. & R.D. Adams. 1980. Harrison's Principles of Internal Medicine, 9th ed. McGraw Hill Book Company Pub, New York.

Kirschmann, J.D. 1990. Nutrition Almanac: Nutrition Search. McGrew-Hill: New York.

Klevay, L.M. & R.A. Jacobs. The Ratio of Zinc to Copper in Cholesterol Lowering Diets. Trace Substances In Environmental Health, 9, D.D. Hemphill, ed. 1975.

Kunz, J.R.M. 1982. The American Medical Association Family Medical Guide. Random House Pub, New York. 832 pp.

Langley-Evans S & Jackson A: Intrauterine programming of hypertension: nutrient-hormone interactions. Nutr Rev, 1996 Jun, 54:6, 163-9.

Lichodziejewska B et al., Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol, 1997 Mar, 79:6, 768-72.

Manson, J.E. et al: A Prospective Study of Antioxidant Vitamins and Incidence of Coronary Heart Disease in Women. Journal of The American College of Nutrition, October 1992;11(5):633/Abstract 119.

Mant D: Effectiveness of dietary intervention in general practice. Am J Clin Nutr, 1997 Jun, 65:6 Suppl, 1933S-1938S.

Murray CJ & Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Harvard School of Public Health, Boston, Massachusetts, USA.
Lancet, 1997 May 3, 349:9061, 1269-76.

Ness AR & Powles JW: Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol, 26:1-13, 1997 Feb.

Riales, R. & M.J. Albrink. Effect of Chromium Chloride Supplementation on Glucose Tolerance and Serum Lipids in Adult Men. American Journal Of Clinical Nutrition, 34. 1981.

Ritz E: Why are lipids not predictive of cardiovascular death in the dialysis patient? Miner Electrolyte Metab, 1996, 22:1-3, 9-12.

Superko HR: What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials? Curr Opin Lipidol, 7(6):363-8 1996 Dec.

Thomas, C.L. 1985. Taber's Cyclopedic Medical Dictionary. F.A. Davis Co. Pub., Philadelphia. 2170 pp.

Traversi E et al., Sleep disorders and breathing alterations in patients with chronic heart failure. G Ital Cardiol, 27:423-9, 1997 May.

Walji, Hasnain. 1994. Heart Health. A Self-help Guide to combining Orthodox & Complementary Approaches . Hodder Headline Plc.London.

Werbach, M. R.: Nutritional Influences on Illness: A sourcebook of clinical research. Keats Pbng. New Canaan, CT.

Werbach, M. R.: Nutritional Influences on Illness: A sourcebook of clinical research. Third Line Press, Tarzana, CA. Second Edition.

Angina Pectoris

Drown-DJ: Postprandial angina pectoris: an indication of the severity of coronary disease. Prog-Cardiovasc-Nurs. 1994 Summer; 9(3): 41.

Duthie-GGm et al: Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris. Nutrition. 1994 Jul-Aug; 10(4): 313-6.

Gey-KF et al: Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am-J-Clin-Nutr. 1993 May; 57(5 Suppl): 787S-797S.

Harano-Y. et al: Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects. Diabetes. 1996 Jul; 45 Suppl 3: S31-4


Altura, B.M.et al: Magnesium deficiency potentiates coronary arterial spasms induced by alcohol. J. Am. Coll. Nutr. 1991, 114: 147-150. (Abstract)

Charnock, J.S. et al: Dietary fats and oils in cardiac arrhythmia in rats. Am. J. Clin. Nutr. 1991, 53: 1047S-1049S.

Chazov, E.L. et al: taurine and electrical activity of the heart. Circ. Res. 1974, 35 (Supp. 3): 11-21.

Cohen, L. & Kitzes, R.: Magnesium deficiency and digitalis toxicity. JAMA. 1984, 251: 730.

Cohen, L. & Kitzes, R.: Magnesium sulfate and digitalis-toxic arrhythmias. JAMA. 1983, 249: 2808-2810.

Crass, M.F. & Lombardini, J.B.: Release of tissue taurine from the oxygen-deficient perfused rat heart. Proc. Soc. Exp. Biol. Med. 1978, 157: 486-488.

DeCarli, C. Et al: Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am. J. Cardiol. 1986, 57: 956.

DiPalma, J.R. et al: Cardiovascular and antiarrhythmic effects of carnitine. Arch. Int. Pharmacdyn. Ther. 1975, 217(2): 246-250.

Dobmeyer, D.J. et al: The arrhythmogenic effects of caffeine in human beings. NEJM. 1983, 308(14): 814-816.

Dychner, T. & Werster, P.O.: Magnesium and potassium in serum and muscle in relation to disturbances of cardiac rhythm. In: Magnesium in Health and Disease, Spectrum. 1980.

Frustaci, A. Et al: Myocardial magnesium content, histology and arrhythmic response to magnesium infusion. Lancet, 1987, 2: 1019. (Letter)

Fuenmayor, A.J. et al: Vitamin E and ventricular fibrillation threshold in myocardial ischemia. Japan Circ. J. 1989, 53: 1229-1232.

Fujioka, T. Et al: Clinical study of cardiac arrhythmias using 24-hour continuous electrocardiographic recorder (5th report): antiarrhythmic action of coenzymeQ10 in diabetics. Tohoku J. Exp. Med. 1983, 141(Supp): 453-463. .

Grujic, M. & Perinovic, M.: [Treatment of acute myocardial infarction and chronic heart failure with K-Mg aspartate.] Med. Welt. 1974 25(50): 2124-2126. (German)

Holland, O.B. et al: Venbtricular extopic activity with diuretic therapy. Am. J. Hypertens. 1988,1(4 Pt 1): 380-385.

Jalili-T. Et al: Aspects of cardiomyopathy are exacerbated by elevated dietary fat in copper-restricted rats. J-Nutr. 1996 Apr; 126(4): 807-16.

Kafka, H. Et al: Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Arch. Int. Med. 1987,147(3): 465-469.

Kessel, L.: Sick sinus syndrome cured by vitamin D. Geriatrics, 1990, 45: 83-85.

Klevay, L.M.: Atrial thrombosis, abnormal elexctrocradiograms and sudden death in mice due to copper deficiency. Atherosclerosis, 1985, 54(2): 213-224.

Lombardini, J.B. & Cooper, M.W.: Elevated blood taurine levels in acute and evolving myocardial infarction. J. Lab. Clin. Med. 1981, 98(6): 849-859.

Manso-CF.: [Pathologic states related to alcoholism]. Acta-Med-Port. 1995 Dec; 8(12): 711-7.

Marcus-RW.: Myopathy and cardiomyopathy associated with selenium deficiency: case report, literature review, and hypothesis. Md-Med-J. 1993 Jul; 42(7): 669-74.

McLennan-PL et al: Reversal of arrhythmogenic effects of long-term saturated fatty acid intake by dietary n-3 and n-6 polyunsaturated fatty acids. Am. J. Clin. Nutr. 1990, 51: 53-58.

McLennan-PL & Dallimore-JA.: Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. J-Nutr. 1995 Apr; 125(4): 1003-9.

Medeiros-DM. Et al: A unified perspective on copper deficiency and cardiomyopathy [see comments]. Proc-Soc-Exp-Biol-Med. 1993 Jul; 203(3): 262-73.

Moushmoush, B. & Abi-Mansour, P. : Alcohol and the heart. The long-term effects of alcohol on the cardiovascular system. Arch. Intern. Med. 1991, 151: 36-42.

Nordrehaug, J. Et al: Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation, 1985, 71(4): 645-649.

Rea, W.J. & Suits, C.W.: Cardiovascular disease triggered by foods and chemicals. In: Gerrard, J.W. (Ed): Food Allergy: New Perspectives. C.C. Thomas, Springfield, IL. 1980.

Regan, T.J.: Alcohol and the cardiovascular system. JAMA, 1990, 264(3): 377-381.
Roden, D.M.: Magnesium treatment of ventricular arrhythmias. Am. J. Cardiol. 1989, 63(14): 43G-46G.

Sangiori, G.B. et al: Serum potassium levels, red-blood-cell potassium and alterations of the repolaraization phase of electrocardiography of old subjects. Age Aging, 1984, 13: 309.

Sebring, L.A. & Huxtable, R.J.: Sulfur Amino Acids: Biochemical & Clinical Aspects. 1983.

Spencer, J.C.: Direct relationship between the body’s copper/zinc ratio, ventricular premature beats and sudden cardiac death. Am. J. Clin. Nutr. 1979: 1184-1185. (Letter)

Topping-D.: Dietary fatty acids and protection against experimental cardiac arrhythmias in rats. Nutr-Rev. 1993 Sep; 51(9): 271-3.

Congestive Heart Failure (CHF)

Altura, B.M. & Altura, B.T.: Biochemistry and pathophysiology of congestive heart failure: is there a role for magneisum? Magnesium, 1986, 5(3-4): 134-143.

Azuma, J. et al: Double-blind randomized crossover trial of taurine in congestive heart failure. Curr. Ther. Res. 1983, 34(4): 543-557.

Azuma, J. et al: Therapeutic effect of taurine in congestiv eheart failure: a double-blind crossover trial. Clin. Cardiol. 1985, 8: 276-282.

Azuma, J. et al: Taurine and failing heart: experimental and clinical aspects. Progh. Clin. Biol. Res. 1985, 179: 195-213.

Brady-JA et al: Thiamin status, diuretic medications, and the management of congestive heart failure. J-Am-Diet-Assoc. 1995 May; 95(5): 541-4.

Brink-M et al: Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J-Clin-Invest. 1996 Jun 1; 97(11): 2509-16.

Broqvist-M et al: Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure--effects of long-term dietary supplementation. Eur-Heart-J. 1994 Dec; 15(12): 1641-50.

Chin-Dusting-JP et al: Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J-Am-Coll-Cardiol. 1996 Apr; 27(5): 1207-13.

Cody-RJ et al: Diuretic treatment for the sodium retention of congestive heart failure. Arch-Intern-Med. 1994 Sep 12; 154(17): 1905-14

Culpepper-Morgan-JA et al: Using enteral nutrition formulas. Gastroenterologist. 1993 Jun; 1(2): 143-57.

Dracup-K et al: Management of heart failure. II. Counseling, education, and lifestyle modifications. JAMA. 1994 Nov 9; 272(18): 1442-6.

Forchielli-ML et al: Children with congenital heart disease: a nutrition challenge. Nutr-Rev. 1994 Oct; 52(10): 348-53.

Freeman-LM & Roubenoff-R.: The nutrition implications of cardiac cachexia. Nutr-Rev. 1994 Oct; 52(10): 340-7.

Gottleib, S.S. et al: Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J. Am. Coll. Cardiol. 1990,: 827-831.

Karon-BL: Diagnosis and outpatient management of congestive heart failure. Mayo-Clin-Proc. 1995 Nov; 70(11): 1080-5.

Kitamura, N. Et al: Myocardial tissue level of coenzyme Q10 in patients with cardiac failure. In: Folkers, K. & Yamamura, Y. (Eds): Biomedical and Clinical Aspects of Coenzyme Q. Elsevier, Amsterdam, 1984: 243-252.

Little-DR: Hemochromatosis: diagnosis and management. Am-Fam-Physician. 1996 Jun; 53(8): 2623-8, 2631-2.

Mortensen, S.A. et al: Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. Int. J. Tissue React. 1990, 12(3): 155-162.

Moser-DK Maximizing therapy in the advanced heart failure patient. J-Cardiovasc-Nurs. 1996 Jan; 10(2): 29-46.

Opie, L.H. Principles of therapy for congestive heart failure. Eur. Heart J. 1983, 4(Supp A): 199-208.

Paccagnella-A et al: Cardiac cachexia: preoperative and postoperative nutrition management. JPEN-J-Parenter-Enteral-Nutr. 1994 Sep-Oct; 18(5): 409-16.

Packer, M.: Potential role of potassium as determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure. Am. J. Cardiol. 1990,65(10):45E-51E.

Pelouch-V et al: Role of extracellular matrix proteins in heart function. Mol-Cell-Biochem. 1993 Dec 22; 129(2): 101-20.

Poehlman-ET et al: Increased resting metabolic rate in patients with congestive heart failure [see comments]. Ann-Intern-Med. 1994 Dec 1; 121(11): 860-2.

Preuss-HG: Nutrition and diseases of women: cardiovascular disorders. J-Am-Coll-Nutr. 1993 Aug; 12(4): 417-25.

Prida, X.E. et al: Evaluation of calcium-mediated vasoconstriction in chronic congestive heart failure. Am. J. Med. 1983, 75(5): 795-800.

Sawamura, A. & Awata, N.: Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn. Circ. J. 1992, 56(1): 95-99.

Takihara, K. Et al: Beneficial effects of taurine in rabbits with chronic congestive heart failure. Am. Heart J. 1986, 112: 1278.

Valensi-P. : [Hemodynamics of massive obesity]. Rev-Prat. 1993 Oct 1; 43(15): 1918-23.

Weaver T & Eisold JF: Congestive heart failure and disorders of the heart beat. Dent Clin North Am, 40:543-61, 1996 Jul.

Wester, P.O. & Dyckner, T.: Intracellular electrolytes in cardiac failure. Acta Med. Scand. (Supp). 1986, 707: 33 -36.


Follow Applied Health on FaceBook Follow Applied Health on Twitter Follow Applied Health on Pinterest Follow Applied Health on YouTube

cruelty free - tested only on humans
We test only on humans